The Hair Loss Encyclopedia

Search

for
Search:

Products matching "topical hydroquinone"

Tracking 3 products like 309 Skin Lite, 309 Skin Lite and 309 Skin Lite from by companies like Amazon and AllDayChemist. View all 3 products »

Sort by

Research

990-1000 / 1000+ results

Efficacy and Safety of Topical Finasteride Spray Solution in the Treatment of Chinese Men with Androgenetic Alopecia: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

research Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study

March 2025 in “Chinese Medical Journal”

Topical finasteride effectively and safely increases hair growth in men with hair loss.

Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with Localized Alopecia Areata: A Triple-Arm Randomized Clinical Study

research Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with Localized Alopecia Areata: A Triple-Arm Randomized Clinical Study

February 2025 in “Indian Dermatology Online Journal”

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

Analyzing Efficacy of Low-Dose Oral Minoxidil, Topical Minoxidil, and Platelet-Rich Plasma with Topical Minoxidil Combination in Patients with Androgenetic Alopecia: A Randomized Controlled Observer Blinded Trial

research Analysing efficacy of low-dose oral minoxidil, topical minoxidil, and platelet-rich plasma with topical minoxidil combination in patients with androgenetic alopecia: a randomized controlled observer blinded trial

February 2025 in “Archives of Dermatological Research”

Combining PRP with topical minoxidil is most effective for hair growth in androgenetic alopecia.

Assessing the Safety of Topical Minoxidil Through Disproportionality Analysis of FAERS Reports

research Assessing the safety of topical minoxidil through disproportionality analysis of FAERS reports

February 2025 in “Expert Opinion on Drug Safety”

Topical minoxidil may cause more side effects than currently listed, needing updated safety information.

Clascoterone: A New Topical Antiandrogen Agent

research Clascoterone: a new topical antiandrogen agent.

February 2025 in “Prospects in Pharmaceutical Sciences”

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

The Pharmacokinetics of Topical Finasteride 0.25% Spray in Chinese Adult Male Volunteers with Androgenic Alopecia: A Phase I Study

research The Pharmacokinetics of Topical Finasteride 0.25% Spray in Chinese Adult Male Volunteers with Androgenic Alopecia: A Phase I Study

February 2025 in “Advances in Therapy”

The topical finasteride spray was safe and well-tolerated with stable effects.

Comparative Study Evaluating the Effectiveness of Intradermotherapy with 0.5% Minoxidil Versus Topical Application of 5% Minoxidil Solution in the Treatment of Androgenetic Alopecia

research Comparative Study That Evaluates the Effectiveness of Intradermotherapy with 0.5% Minoxidil Versus Topical Application of 5% Monoxidil Solution in the Treatment of Androgenetic Alopecia

January 2025

Intradermotherapy with minoxidil is as effective as topical application for treating hair loss.

Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment

research Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment

January 2025 in “Dermatology Practical & Conceptual”

Topical finasteride is as effective and safe as minoxidil for treating female pattern hair loss.

Comparing the Efficacy of Combined Intralesional Triamcinolone Acetonide With Topical Calcipotriol Versus Intralesional Triamcinolone Acetonide Monotherapy in Scalp and Beard Alopecia Areata: Results From a Randomized Single-Blinded Clinical Trial

research Comparing the Efficacy of Combined Intralesional Triamcinolone Acetonide With Topical Calcipotriol Versus Intralesional Triamcinolone Acetonide Monotherapy in Scalp and Beard Alopecia Areata: Results From a Randomized Single-Blinded Clinical Trial

January 2025 in “Journal of Cutaneous Medicine and Surgery”

The combination treatment was more effective for scalp hair regrowth but caused more irritation.

An Update on Nanocarriers for Follicular-Targeted Drug Delivery for Androgenetic Alopecia Topical Treatment

research An update on nanocarriers for follicular-targeted drug delivery for androgenetic alopecia topical treatment

January 2025 in “Expert Opinion on Drug Delivery”

Nanocarriers could improve hair loss treatment but need more research for effectiveness and safety.

← Previous page